INDIGO
Giving People with diabetes the extra sense for healthHassle-free Glucose Monitoring
Indigo is developing the next-generation Continuous Glucose Monitoring (CGM) systems that will give you the power to know your glucose level and trends at any moment without having to wear anything on your body.
You will have the power to live your life, hassle-free and worry-free, and with the assurance that your diabetes is accurately monitored in the background.
Indigo’s CGM system and App are currently being developed. We suggest you regularly revisit this website to find out when our CGM system becomes available in your country.
Indigo
The color indigo owes its position in the color spectrum to Isaac Newton, who established indigo as the 7th color.
Indigo is neither a primary nor a secondary color. The human eye is hardly capable to detect the nuances of indigo, so it takes a specific sensitivity to mark the color variety.
For reasons of perfection however, Newton added indigo to the set of six primary and secondary colors (red, orange, yellow, green, blue, violet) to have the spectrum in accordance to music (7 notes), the seven heavenly bodies (planets and sun and moon) known at the time, and the seven days of the week.
indigo was the color of light that was missing in the spectrum to make it perfect, and that is Indigo’s mission.
Indigo was the color of light that was missing in the spectrum to make it perfect, and that is Indigo’s mission.
NEWS
Join our team as Clinical Affairs Manager
At Indigo we are working to improve the quality of life of millions of people with diabetes. Want to join our young dynamic team? We are hiring a Clinical Affairs Manager. Please visit our careers page for more information.
Indigo at ADA 2019 Conference
Indigo will be present during the ADA 2019 conference on June 7-11 in San Francisco, USA. If you are interested to talk to us, we will be delighted to meet you. Please contact us danae.delbeke@indigomed.com (+32 475 41 21 32) or tom.segers@indigomed.com (+32 496 59 07...
Clinical Study Action-1 kicked-off: T1D in action for Ketones and Lactate
Indigo is pleased to announce that the first patient has now been enrolled into ‘Action-1”, the company’s prospective, non-randomized, interventional, multi-center data collection study. The study collects venous blood samples in male T1D patients to evaluate the...
“We are proud to pioneer groundbreaking technology that will have a positive impact on the life of millions of people living with diabetes.”
– Danaë Delbeke